献血者选择与献血适宜性-献血年龄上限与献血间隔期调整刍议

胡雨薇 ,  李玲 ,  王珏 ,  刘忠

中国输血杂志 ›› 2026, Vol. 39 ›› Issue (9) : 1141 -1146.

PDF (1279KB)
中国输血杂志 ›› 2026, Vol. 39 ›› Issue (9) : 1141 -1146. DOI: 10.13303/j.cjbt.issn.1004-549x.2026.09.001
专家述评

献血者选择与献血适宜性-献血年龄上限与献血间隔期调整刍议

作者信息 +

Blood donor selection and suitability for blood donation: a discussion on adjusting the upper age limit and interval for whole blood donation

Author information +
文章历史 +
PDF (1309K)

摘要

献血者筛查标准是保障献血者与受血者安全、维护血液供应充足与可及的核心环节。 百余年来,随着血库体系建立及经血传播病原体识别,健康征询、体格检查和实验室检测逐步纳入筛查流程,保障了血液服务安全、可靠且有效地运转。 而近数十年来随着科学技术不断提升,人类对于人体的认识也不断加深。 因此有必要对献血者筛查标准设置的科学性、必要性和合理性系统地进行反思和再认知。 本文作为本期全血献血间隔与献血年龄上限系列文章的导论性刍议,围绕献血者筛查标准形成与动态调整逻辑,结合本期相关专家共识及我国多中心真实世界研究概况,探讨献血安全与血液供应之间的平衡,并从政策本土化、循证施策和试点评估三个层面提出我国献血者筛查标准优化的未来方向。

Abstract

Objective Blood donor selection criteria provide the core framework for assessing whether a prospective donor is suitable to donate blood, with the dual aim of protecting donor health and recipient safety while supporting a sufficient and accessible blood supply. Over the past century, with the establishment of blood banking systems and the progressive identification of transfusion-transmissible pathogens, health questionnaires, physical assessment and laboratory testing have become integral parts of the donor selection process, contributing to the safe, reliable and effective operation of blood services. In recent decades, advances in science and technology, together with a deeper understanding of human physiology, disease risk and transfusion safety, have made it necessary to systematically re-examine the scientific basis, necessity and appropriateness of existing donor selection criteria. As an introductory commentary to this series on whole-blood interdonation intervals and the upper age limit for blood donation, this article discusses the rationale underlying the establishment and dynamic adjustment of donor selection criteria. Drawing on the relevant expert consensus statements in this series and an overview of multicenter real-world studies from China, it explores the balance between donor safety and blood supply sufficiency and proposes future directions for optimizing donor selection criteria in China through local adaptation of policies, evidence-informed decision-making, and pilot evaluation.

关键词

献血者筛查 / 献血者选择 / 献血适宜性 / 血液安全 / 血液供应

Key words

blood donor screening / blood donor selection / donor eligibility / blood safety / blood supply

引用本文

引用格式 ▾
胡雨薇,李玲,王珏,刘忠. 献血者选择与献血适宜性-献血年龄上限与献血间隔期调整刍议[J]. 中国输血杂志, 2026, 39(9): 1141-1146 DOI:10.13303/j.cjbt.issn.1004-549x.2026.09.001

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

WORLD HEALTH ORGANIZATION. Blood Donor Selection:Guidelines on Assessing Donor Suitability for Blood Donation[M]. Geneva: World Health Organization, 2012.

[2]

WORLD HEALTH ORGANIZATION. The Melbourne Declaration on 100% voluntary non-remunerated donation of blood and blood components[R/OL].(2009-06-11)[2026-09-02].https://www.who.int/publications/m/item/the-melbourne-declaration.

[3]

REISS R F. Blood donor well-being:a primary responsibility of blood collection agencies[J].Ann Clin Lab Sci, 2011, 41(1):3-7.

[4]

WHO EXPERT GROUP. Expert consensus statement on achieving self-sufficiency in safe blood and blood products, based on voluntary non-remunerated blood donation (VNRBD)[J].Vox Sang, 2012, 103 (4):337-342.

[5]

EDER A, GOLDMAN M, ROSSMANN S,et al. Selection criteria to protect the blood donor in North America and Europe:past (dogma), present (evidence), and future (hemovigilance)[J].Transfus Med Rev, 2009, 23 (3):205-220.

[6]

WORLD HEALTH ORGANIZATION. Safe blood and blood products:distance learning materials[M]. Geneva:World Health Organization,2002.

[7]

DODD R Y. Current estimates of transfusion safety worldwide[J].Dev Biol (Basel), 2005, 120:3-10.

[8]

STRAMER S L, DODD R Y. Transfusion-transmitted emerging infectious diseases:30 years of challenges and progress[J].Transfusion, 2013, 53(10 Pt 2):2375-2383.

[9]

Expert Consensus Statement on achieving self-sufficiency in safe blood and blood products, based on voluntary non-remunerated blood donation[J].Vox Sang, 2012, 103(4):337-342.

[10]

EUROPEAN DIRECTORATE FOR THE QUALITY OF MEDICINES & HEALTHCARE. Guide for the preparation, use and quality assurance of blood components[M]. 22nd ed. Strasbourg:European Directorate for the Quality of Medicines & HealthCare,2025.

[11]

YU X, WANG Z, SHEN Y, et al. Population-based projections of blood supply and demand, China, 2017-2036[J].Bull World Health Organ, 2020, 98(1):10-18.

[12]

HU W, MENG H, HU Q, et al. Blood donation from 2006 to 2015 in Zhejiang Province, China:annual consecutive cross-sectional studies[J].BMJ Open, 2019, 9 (5):e023514.

[13]

巩晗实, 陈睿, 段勇,等. 1998-2024 年西安市无偿献血人群特征变化趋势分析[J].中华预防医学杂志, 2026, 60(6):983-987.

[14]

GONG H S, CHEN R, DUAN Y, et al. Analysis of the changing trends of characteristics of voluntary blood donors in Xi′an City from 1998 to 2024[J].Chin J Prev Med, 2026, 60(6):983-987.

[15]

WITTOCK N, HUSTINX L, BRACKE P, et al. Who donates? Cross-country and periodical variation in blood donor demographics in Europe between 1994 and 2014[J].Transfusion, 2017, 57(11):2619-2628.

[16]

WORLD HEALTH ORGANIZATION, UNITED NATIONS CHILDREN′S FUND, UNITED NATIONS UNIVERSITY. Iron deficiency anaemia: assessment, prevention and control. A guide for programme managers[M]. Geneva:World Health Organization,2001.

[17]

DE BENOIST B, MCLEAN E, EGLI I, et al. , eds. Worldwide prevalence of anaemia 1993-2005: WHO Global Database on Anaemia[M]. Geneva: World Health Organization, 2008.

[18]

BRITTENHAM G M. Iron deficiency in whole blood donors[J].Transfusion, 2011, 51(3):458-461.

[19]

苏玲玲, 陈镇奇, 翁妙卿, 等. 无偿献血的限量及安全间隔期的研究[J].临床输血与检验, 2007, 9(4): 302-304.

[20]

SU L L, CHEN Z Q, WENG M Q, et al. Research to the satisfying blood donating volume and safe interval[J].J Clin Transfus Lab Med, 2007, 9(4):302-304.

[21]

宁理, 张艳艳, 曾劲峰, 等. 深圳地区献血间隔期与献血不良反应相关性的回顾性队列分析[J].中国输血杂志, 2026, 39(3):346-352.

[22]

NING L, ZHANG Y Y, ZENG J F, et al. A retrospective cohort analysis on the association between blood donation intervals and adverse reactions to blood donation in Shenzhen, China[J].Chin J Blood Transfusion, 2026, 39(3):346-352.

[23]

王鸿捷. 献血者铁缺乏:现状与管理[J].中国输血杂志, 2021, 34(1):1-4.

[24]

WANG H J. Blood donor iron deficiency: status and management[J].Chin J Blood Transfusion, 2021, 34 (1):1-4.

[25]

BAART A M, VAN DEN HURK K, DE KORT W L A M. Minimum donation intervals should be reconsidered to decrease low hemoglobin deferral in whole blood donors:an observational study[J].Transfusion, 2015, 55 (11):2641-2644.

[26]

GANDHI M J, DUFFY K, BENIKE M, et al. Effect of increasing hemoglobin cutoff in male donors and increasing interdonation interval in whole blood donors at a hospital-based blood donor center[J].Transfusion, 2012, 52(9):1880-1888.

[27]

SPENCER B R, JOHNSON B, WRIGHT D J, et al. Potential impact on blood availability and donor iron status of changes to donor hemoglobin cutoff and interdonation intervals[J].Transfusion, 2016, 56(8):1994-2004.

[28]

MITTAL R, MARWAHA N, BASU S, et al. Evaluation of iron stores in blood donors by serum ferritin[J].Indian J Med Res, 2006, 124(6):641-646.

[29]

FARRUGIA A. Iron and blood donation-an under-recognised safety issue[J].Dev Biol (Basel), 2007, 127: 137-146.

[30]

ALVAREZ-OSSORIO L, KIRCHNER H, KLÜTER H, et al. Low ferritin levels indicate the need for iron supplementation:strategy to minimize iron-depletion in regular blood donors[J].Transfus Med, 2000, 10(2):107-112.

[31]

O′MEARA A, INFANTI L, STEBLER C, et al. The value of routine ferritin measurement in blood donors[J].Transfusion, 2011, 51(10):2183-2188.

[32]

马维娟, 王同显, 马保凤. 献血相关性铁缺乏及其应对策略[J].中国输血杂志, 2017, 30 (11):1307-1311.

[33]

MA W J, WANG T X, MA B F. Donation-induced iron deficiency and its solutions[J].Chin J Blood Transfusion, 2017, 30(11):1307-1311.

[34]

DI ANGELANTONIO E, THOMPSON S G, KAPTOGE S, et al. Efficiency and safety of varying the frequency of whole blood donation (INTERVAL):a randomised trial of 45 000 donors[J].Lancet, 2017, 390 (10110): 2360-2371.

[35]

SEVERIJNS P, D′AES T, DE BUCK E, et al. What is the impact of whole-blood donation frequency on donor health? A systematic review[J].Vox Sang, 2026, 121 (7):893-903.

[36]

KARREGAT J, MEULENBELD A, ABUBAKAR J, et al. Iron deficiency-related symptoms in non-anemic whole blood donors[J].Transfusion, 2024, 64(10): 1920-1930.

[37]

GOLDMAN M, GERMAIN M, GRÉGOIRE Y, et al. Safety of blood donation by individuals over age 70 and their contribution to the blood supply in five developed countries:a BEST Collaborative group study[J].Transfusion, 2019, 59(4):1267-1272.

[38]

DAVISON T E, MASSER B M, THORPE R. Growing evidence supports healthy older people continuing to donate blood into later life[J].Transfusion, 2019, 59 (4):1166-1170.

[39]

HYDE M K, MASSER B M, THORPE R, et al. Rethinking the role of older donors in a sustainable blood supply[J].Transfusion, 2025, 65(4):758-766.

[40]

EDER A F, DY B A, KENNEDY J M, et al. The American Red Cross donor hemovigilance program:complications of blood donation reported in 2006[J].Transfusion, 2008, 48(9):1809-1819.

[41]

IMADA H, AKITA T, SUGIYAMA A, et al. Trend of blood donors entering the coronavirus pandemic era and challenges:Age-period-cohort analysis using 75. 5 million all blood donations data during 2006-2020 in Japan[J].Transfusion, 2023, 63(6):1184-1194.

[42]

JAPANESE RED CROSS SOCIETY. Blood services 2018[R]. Tokyo:Blood Service Headquarters, Japanese Red Cross Society,2018.

[43]

TAKANASHI M, ODAJIMA T, AOTA S, et al. Risk factor analysis of vasovagal reaction from blood donation[J].Transfus Apher Sci, 2012, 47(3):319-325.

[44]

SHEHATA N, KUSANO R, HANNACH B, et al. Reaction rates in allogeneic donors[J].Transfus Med, 2004, 14(5):327-333.

[45]

ZEILER T, LANDER-KOX J, ALT T. Blood donation by elderly repeat blood donors[J].Transfus Med Hemother, 2014, 41(4):242-250.

[46]

伍立桃, 张艳艳, 曾劲峰,等. 深圳地区献血者年龄与献血不良反应相关性的回顾性队列分析[J].中国输血杂志, 2026, 39(3):353-359.

[47]

WU L T, ZHANG Y Y, ZENG J F, et al. A retrospective cohort analysis on the association between blood donor age and adverse reactions to blood donation in Shenzhen[J].Chin J Blood Transfusion, 2026, 39(3):353-359.

[48]

FUNG Y L, LEE C K, KWON S Y, et al. The contribution and potential of older blood donors in asia pacific regions[J].Transfus Med, 2022, 32(1):71-76.

[49]

CABLE R G, GLYNN S A, KISS J E, et al. Iron deficiency in blood donors:the REDS-II Donor Iron Status Evaluation (RISE) study[J].Transfusion, 2012, 52 (4):702-711.

[50]

SALVIN H E, PASRICHA S R, MARKS D C, et al. Iron deficiency in blood donors:a national cross-sectional study[J].Transfusion, 2014, 54(10):2434-2444.

[51]

张燕华, 戴梓宁, 王同显. 延长法定献血年龄的安全性和可行性[J].中国输血杂志, 2020, 33(2):172-175.

[52]

ZHANG Y H, DAI Z N, WANG T X. The safety and feasibility of relaxing the age criteria for blood donors[J].Chin J Blood Transfusion, 2020, 33(2):172-175.

[53]

BAHR T M, CHRISTENSEN T R, TWEDDELL S M, et al. Associations between blood donor sex and age, and outcomes of transfused newborn infants[J].Transfusion, 2023, 63(7):1290-1297.

[54]

AMICO F, EFIRD J T, BRIGGS G D, et al. Association between blood donor demographics and post-injury multiple organ failure after polytrauma[J].Ann Surg, 2023, 277(1):e170-e174.

[55]

EDGREN G, ULLUM H, ROSTGAARD K, et al. Association of donor age and sex with survival of patients receiving transfusions[J].JAMA Intern Med, 2017, 177 (6):854-860.

[56]

CHASSé M, TINMOUTH A, ENGLISH S W, et al. Association of blood donor age and sex with recipient survival after red blood cell transfusion[J].JAMA Intern Med, 2016, 176(9):1307-1314.

[57]

ROUBINIAN N H, WESTLAKE M, ST LEZIN E M, et al. Association of donor age, body mass index, hemoglobin, and smoking status with in-hospital mortality and length of stay among red blood cell-transfused recipients[J].Transfusion, 2019, 59(11):3362-3370.

[58]

VASAN S K, CHIESA F, ROSTGAARD K, et al. Lack of association between blood donor age and survival of transfused patients[J].Blood, 2016, 127 (5): 658-661.

[59]

HEDDLE N M, COOK R J, LIU Y, et al. The association between blood donor sex and age and transfusion recipient mortality:An exploratory analysis[J].Transfusion, 2019, 59(2):482-491.

[60]

SONG M, XUE Z, FAN Y, et al. Significance of alanine aminotransferase testing in blood donor screening in Chongqing, China: a 7-year retrospective analysis[J].Blood&Genomics, 2023, 7(2):103-108.

[61]

常乐, 闫颖, 姬慧敏,等. 我国血液筛查丙氨酸氨基转移酶现行合格标准调整分析[J].中国输血杂志, 2025, 38(4):465-473.

[62]

CHANG L, YAN Y, JI H M, et al. Analysis of the adjustment of current eligibility criteria for alanine aminotransferase levels in blood screening in China[J].Chin J Blood Transfusion, 2025, 38(4):465-473.

[63]

王瑞, 黄力勤, 张婧,等. 实施核酸检测后重新评估献血者 ALT 的检测功效[J].中国输血杂志, 2017, 30(9):1034-1038.

[64]

WANG R, HUANG L Q, ZHANG J, et al. Reevaluation the effect of ALT on blood safety in nucleic acid era[J].Chin J Blood Transfusion, 2017, 30(9):1034-1038.

[65]

国家卫生健康委临床检验中心血液筛查专家组. 中国献血者人群丙氨酸氨基转移酶血液筛查策略调整专家共识[J].中国输血杂志, 2025, 38 (4):455-465.

[66]

EXPERT GROUP ON BLOOD SCREENING, NATIONAL CENTER FOR CLINICAL LABORATORIES, NATIONAL HEALTH COMMISSION. Expert consensus on the adjustment of blood screening strategy for alanine aminotransferase in Chinese blood donor population[J].Chin J Blood Transfusion, 2025, 38(4):455-465.

[67]

党英男, 沙娜·哈勒木别克, 汤戎,等. 青海省藏族自治州献血者丙氨酸氨基转移酶异常原因分析及血液筛查策略的探讨[J]. 中国输血杂志, 2025, 38 (4):502-507.

[68]

DANG Y N, SHANA HALEMU B K, TANG R, et al. Analysis of abnormal ALT in blood donors in five Zang autonomous prefectures of Qinghai Province, China: characteristics and screening strategies[J].Chin J Blood Transfusion, 2025, 38(4):502-507.

[69]

郑欣, 薛原野, 王皓飚,等. 深圳地区献血者丙氨酸转移酶检测结果分析及调整阈值策略的探讨[J].中国输血杂志, 2025, 38(4):488-494.

[70]

ZHENG X, XUE Y Y, WANG H B, et al. Alanine transferase test results and exploration of threshold adjustment strategies for blood donors in Shenzhen, China[J].Chin J Blood Transfusion, 2025, 38(4):488-494.

[71]

BUSCH M P, KORELITZ J J, KLEINMAN S H, et al. Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection: the Retrovirus Epidemiology Donor Study[J].Transfusion, 1995, 35(11):903-910.

[72]

国家卫生健康委员会. 血站技术操作规程(2019 版): 国卫医函〔2019〕98 号[S/OL].(2019-04-28)[2026-09-02]. https://www.nhc.gov.cn/yzygj/c100068/201905/4822b48429044e16baa2739c10fea35e.

[73]

医疗财团法人台湾血液基金会. 血清转胺酶(ALT)[EB/OL].(2023-01-10)[2026-09-02]. https://www.blood.org.tw/xmdoc/cont?xsmsid=0P063552057214634886&sid=0P063610914729510051.

[74]

SEO D H, WHANG D H. The usefulness of the alanine aminotransferase test for blood donors.[J].Korean J Blood Transf, 2009, 20(3):159-166.

[75]

杨柳, 李萍. 无偿献血前后血压变化规律及影响因素分析[J].实验与检验医学, 2020, 38(3):603-604.

[76]

YANG L, LI P. Analysis of blood pressure changes before and after voluntary blood donation and their influencing factors[J].Exp Lab Med, 2020, 38 (3):603-604.

[77]

EDER A. Evidence-based selection criteria to protect blood donors[J].J Clin Apher, 2010, 25 (6):331-337.

[78]

PAUWELS N S, CUSACK L, DE BUCK E, et al. The effect of pre-donation hypotension on whole blood donor adverse reactions: a systematic review[J].J Am Soc Hypertens, 2014, 8(6):429-436.

[79]

DONALD S J, MCINTYRE W F, DINGWALL O, et al. Is donating blood for the faint of heart? a systematic review of predictors of syncope in whole blood donors[J].Transfusion, 2019, 59(9):2865-2869.

[80]

SALVADORI U, SANDRI M, CEMIN R, et al. Effect of a liberal versus a restrictive pre-donation blood pressure policy on whole-blood donor adverse reactions[J].Vox Sang, 2019, 114(4):317-324.

[81]

WIERSUM-OSSELTON J C, POLITIS C, RICHARDSON C, et al. Complications of blood donation reported to haemovigilance systems:analysis of eleven years of international surveillance[J].Vox Sang, 2020, 116(6): 628-636.

[82]

THIBEAULT C, LEWIN A, RABUSSEAU I, et al. Deferring blood donors with out-of-range blood pressure: Does it decrease the risk of adverse reactions?[J].Transfusion, 2025, 65(6):1083-1091.

[83]

STAINSBY D, BRUNSKILL S, CHAPMAN C E, et al. Safety of blood donation from individuals with treated hypertension or non-insulin dependent type 2 diabetes -a systematic review[J].Vox Sang, 2010, 98(3 Pt 2): 431-440.

[84]

JOHNSEN K M N, MAGNUSSEN K, ERSTAD C, et al. Safe blood donation from donors using antihypertensive medication. A multi-Center retrospective quality study from south-east norway[J].J Blood Med, 2023, 14: 337-343.

[85]

WU Y, QI H, DI ANGELANTONIO E, et al. Risk factors for vasovagal reactions in blood donors:A systematic review and meta-analysis[J].Transfusion, 2025, 65 (1):211-223.

[86]

献血者健康检查之血压筛查策略专家共识编写组. 中国献血者人群献血前血压筛查策略调整的专家共识[J].中国输血杂志, 2025, 38(5):595-604.

[87]

WRITING GROUP OF EXPERT CONSENSUS ON BLOOD PRESSURE SCREENING STRATEGY IN BLOOD DONOR HEALTH EXAMINATION. Expert consensus on adjustment of pre-donation blood pressure screening requirements for blood donor population in China[J].Chin J Blood Transfusion, 2025, 38(5):595-604.

[88]

SEIFRIED E, KLUETER H, WEIDMANN C, et al. How much blood is needed?[J].Vox Sang, 2010, 100(1):10-21.

[89]

CUSTER B, JOHNSON E S, SULLIVAN S D, et al. Community blood supply model:Development of a new model to assess the safety, sufficiency, and cost of the blood supply[J].Med Decis Making, 2005, 25(5): 571-582.

基金资助

基地平台建设项目(医科院重点实验室)(2018PT32016)

AI Summary AI Mindmap
PDF (1279KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉